J. Mertin

2.9k total citations
59 papers, 2.2k citations indexed

About

J. Mertin is a scholar working on Immunology, Nutrition and Dietetics and Pharmacology. According to data from OpenAlex, J. Mertin has authored 59 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 17 papers in Nutrition and Dietetics and 13 papers in Pharmacology. Recurrent topics in J. Mertin's work include Fatty Acid Research and Health (17 papers), Immune Response and Inflammation (16 papers) and Multiple Sclerosis Research Studies (13 papers). J. Mertin is often cited by papers focused on Fatty Acid Research and Health (17 papers), Immune Response and Inflammation (16 papers) and Multiple Sclerosis Research Studies (13 papers). J. Mertin collaborates with scholars based in United Kingdom, United States and Germany. J. Mertin's co-authors include Christopher J. Meade, Arthur Stackpoole, David Hughes, Ruth Hunt, Alice Nieuwboer, Geert Verheyden, Willy De Weerdt, Carlotte Kiekens, Rudolf Preger and S C Knight and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

J. Mertin

55 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Mertin United Kingdom 25 635 577 393 372 297 59 2.2k
Mohammed M. Sayeed United States 23 481 0.8× 144 0.2× 140 0.4× 438 1.2× 191 0.6× 60 1.4k
Marina Korotkova Sweden 30 324 0.5× 589 1.0× 71 0.2× 709 1.9× 42 0.1× 77 2.5k
J. J. Spitzer United States 28 401 0.6× 290 0.5× 267 0.7× 574 1.5× 40 0.1× 113 2.5k
Alexandra C. Kendall United Kingdom 22 265 0.4× 200 0.3× 109 0.3× 413 1.1× 192 0.6× 44 1.5k
S. F. Orencole United States 13 694 1.1× 196 0.3× 46 0.1× 500 1.3× 368 1.2× 18 1.8k
Michael Shipley United Kingdom 14 645 1.0× 119 0.2× 118 0.3× 409 1.1× 28 0.1× 24 2.3k
Neus Carbó Spain 30 399 0.6× 195 0.3× 82 0.2× 1.4k 3.7× 547 1.8× 82 2.9k
Asha Jacob United States 29 1.0k 1.6× 195 0.3× 161 0.4× 998 2.7× 51 0.2× 84 3.0k
Michael Ombrellino United States 8 1.4k 2.3× 250 0.4× 188 0.5× 1.0k 2.7× 25 0.1× 12 3.5k
Javier Conde Spain 28 379 0.6× 175 0.3× 108 0.3× 667 1.8× 49 0.2× 70 2.8k

Countries citing papers authored by J. Mertin

Since Specialization
Citations

This map shows the geographic impact of J. Mertin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mertin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mertin more than expected).

Fields of papers citing papers by J. Mertin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mertin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mertin. The network helps show where J. Mertin may publish in the future.

Co-authorship network of co-authors of J. Mertin

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mertin. A scholar is included among the top collaborators of J. Mertin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mertin. J. Mertin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mertin, J., et al.. (2015). Modulation of in vivo Immune Responses Following Changes in the Intake of Essential Fatty Acids. Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy. 44. 172–206. 1 indexed citations
2.
Baumhackl, Ulf, Ludwig Kappos, Peter Freitag, et al.. (2005). A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis. Multiple Sclerosis Journal. 11(2). 166–168. 12 indexed citations
3.
Verheyden, Geert, Alice Nieuwboer, J. Mertin, et al.. (2004). The Trunk Impairment Scale: a new tool to measure motor impairment of the trunk after stroke. Clinical Rehabilitation. 18(3). 326–334. 369 indexed citations
4.
Mertin, J.. (1994). Rehabilitation in multiple sclerosis. Annals of Neurology. 36(S1). S130–S133. 9 indexed citations
5.
Wiethölter, H., Johannes Dichgans, & J. Mertin. (1991). Current concepts in multiple sclerosis : proceedings of the 6th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Tübingen, 11-13 October 1990. 1 indexed citations
6.
Yudkin, P, George W. Ellison, Angelo Ghezzi, et al.. (1991). Overview of azathioprine treatment in multiple sclerosis. The Lancet. 338(8774). 1051–1055. 160 indexed citations
7.
Mertin, J. & W. I. McDonald. (1984). Hyperbaric oxygen for patients with multiple sclerosis.. BMJ. 288(6422). 957–960. 8 indexed citations
8.
Mertin, J., Arthur Stackpoole, & Sara J. Shumway. (1984). Prostaglandin E1 in thein vivo induction of cell-mediated immune responses. Inflammation Research. 15(1-2). 65–65. 1 indexed citations
9.
Mertin, J.. (1981). Essential fatty acids and cell-mediated immunity. Progress in Lipid Research. 20. 851–856. 16 indexed citations
10.
Mertin, J. & Arthur Stackpoole. (1979). The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors.. PubMed. 36(3). 449–55. 24 indexed citations
11.
Mertin, J. & Arthur Stackpoole. (1978). Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin. Prostaglandins and Medicine. 1(4). 283–291. 39 indexed citations
12.
Mertin, J. & Christopher J. Meade. (1977). RELEVANCE OF FATTY ACIDS IN MULTIPLE SCLEROSIS. British Medical Bulletin. 33(1). 67–71. 47 indexed citations
13.
Hunt, Robert F., et al.. (1976). Alteration of the immune response in mice by dietary factors: effects of irradiating, autoclaving and essential fatty acid deficiency of rodent diets [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(3). 147A–148A. 1 indexed citations
14.
Ring, Johannes, et al.. (1976). Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis.. PubMed. 52(5 Suppl). 123–30. 9 indexed citations
15.
Mertin, J.. (1975). Diagnostic Test for Multiple Sclerosis. BMJ. 1(5953). 334.5–334. 1 indexed citations
16.
Mertin, J. & David Hughes. (1975). Specific Inhibitory Action of Polyunsaturated Fatty Acids on Lymphocyte Transformation Induced by PHA and PPD. International Archives of Allergy and Immunology. 48(2). 203–210. 118 indexed citations
17.
Mertin, J., B.K. Shenton, & E. J. Field. (1973). Unsaturated fatty acids in multiple sclerosis.. BMJ. 2(5869). 777.3–778. 46 indexed citations
18.
Mertin, J., et al.. (1973). [Use of propranolol in acute intermittent porphyria].. PubMed. 44(12). 648–51. 3 indexed citations
19.
Mertin, J., et al.. (1972). [Pilot study on the efficacy of high doses of aldosterone and spirolactone derivatives in the treatment of multiple sclerosis].. PubMed. 202(3). 217–28. 2 indexed citations
20.
Mertin, J., Hermann Wisser, & Peter Doerr. (1971). Untersuchung über den Normalbereich des Gesamteiweißes und der Eiweißfraktionen des Liquor cerebrospinalis nach elektrophoretischer Trennung auf Celluloseacetatfolie. Clinical Chemistry and Laboratory Medicine (CCLM). 9(4). 337–40. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026